Showing results (201-210 of 232) with videos related to
Sort By:
Pageof 24
Clinical and Experimental Dermatology|August 3, 2021
Development and preliminary evaluation of the Neurofibromatosis Type 1 Adult Quality of Life (NF1-AdQoL) questionnaireH Crawford, K North, M J Wilson, et al.Psychological Reports|April 1, 1991
Comparison of three antismoking interventions among pregnant women in an urban setting: a randomized trialJ H Price, R A Krol, S M Desmond, et al.Plos One|January 29, 2020
Embryonic and foetal expression patterns of the ciliopathy gene CEP164L A Devlin, S A Ramsbottom, L M Overman, et al.Clinical Genetics|June 18, 2015
Uptake of health monitoring and disease self-management in Australian adults with neurofibromatosis type 1: strategies to improve careH A Crawford, B Barton, M J Wilson, et al.British Journal of Obstetrics and Gynaecology|February 1, 1997
A randomised controlled trial evaluating a novel cytotoxic drug delivery system for the treatment of cervical intraepithelial neoplasiaH K Sidhu, J H Price, P A McCarron, et al.Neurology|November 30, 2006
Levetiracetam in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy RegisterS Hunt, J Craig, A Russell, et al.Journal of Medical Genetics|December 1, 1993
Identification of an expanded CAG repeat in the Huntington's disease gene (IT15) in a family reported to have benign hereditary choreaJ C MacMillan, P J Morrison, N C Nevin, et al.Journal of Clinical Pathology|February 5, 2002
Morphological effects of chemotherapy on ovarian carcinomaW G McCluggage, R W Lyness, R J Atkinson, et al.Neurology|July 23, 2008
Topiramate in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy RegisterS Hunt, A Russell, W H Smithson, et al.Journal of Neurology, Neurosurgery, and Psychiatry|September 15, 2005
Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy RegisterJ Morrow, A Russell, E Guthrie, et al.Pageof 24